{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:01:57Z","timestamp":1780750917016,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ab.2026.116158","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:12:29Z","timestamp":1778825549000},"page":"116158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a quantitative LC\u2013MS\/MS method for assessment of xylazine in urine"],"prefix":"10.1016","volume":"716","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2422-2235","authenticated-orcid":false,"given":"Rejwi Acharya","family":"Dahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ab.2026.116158_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodriguez","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.ab.2026.116158_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/clinchem\/hvae163","article-title":"Xylazine pharmacokinetics in patients testing positive for fentanyl and xylazine","volume":"71","author":"Lin","year":"2025","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.ab.2026.116158_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2460\/javma.1987.190.04.423","article-title":"Effects of tolazoline and yohimbine on xylazine-induced central nervous system depression, bradycardia, and tachypnea in sheep","volume":"190","author":"Hsu","year":"1987","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.ab.2026.116158_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J. Urban Health"},{"key":"10.1016\/j.ab.2026.116158_bib5","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine\u2014Medical and public health imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ab.2026.116158_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50630","article-title":"Xylazine in overdose deaths and forensic drug reports in US States, 2019-2022","volume":"7","author":"Cano","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ab.2026.116158_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ab.2026.116158_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2023.102542","article-title":"The first drug-related death associated with xylazine use in the UK and Europe","volume":"97","author":"Rock","year":"2023","journal-title":"J Forensic Leg Med"},{"issue":"6","key":"10.1016\/j.ab.2026.116158_bib10","article-title":"The new stealth drug on the street: a narrative review of xylazine as a street drug","volume":"15","author":"Pergolizzi","year":"2023","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.ab.2026.116158_bib11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7326\/M23-2001","article-title":"Xylazine adulteration of the heroin-fentanyl drug supply: a narrative review","volume":"176","author":"D'Orazio","year":"2023","journal-title":"Ann. Intern. Med."},{"issue":"26","key":"10.1016\/j.ab.2026.116158_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","article-title":"Illicitly manufactured fentanyl\u2013involved overdose deaths with detected Xylazine\u2014United States, January 2019\u2013June 2022","volume":"72","author":"Kariisa","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.ab.2026.116158_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11916-024-01211-z","article-title":"Xylazine: a drug adulterant of clinical concern","volume":"28","author":"Edinoff","year":"2024","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ab.2026.116158_bib14","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1007\/s00216-013-7419-7","article-title":"Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC\u2013MS, LC\u2013MSn, and LC\u2013HR-MSn","volume":"405","author":"Meyer","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ab.2026.116158_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jat\/31.3.165","article-title":"Solid-phase extraction and gas chromatographic-mass spectrometric determination of the veterinary drug xylazine in human blood","volume":"31","author":"Barroso","year":"2007","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ab.2026.116158_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jat\/bkv040","article-title":"Simultaneous determination of xylazine and 2,6-xylidine in blood and urine by auto solid-phase extraction and ultra high performance liquid chromatography coupled with quadrupole-time of flight mass spectrometry","volume":"39","author":"Gao","year":"2015","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.ab.2026.116158_bib17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jat\/bkae055","article-title":"Qualitative and quantitative determination of xylazine in oral fluid","volume":"48","author":"Levitas","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ab.2026.116158_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124059","article-title":"A quantitative LC-MS\/MS analysis of xylazine, p-fluorofentanyl, fentanyl and fentanyl-related compounds in postmortem blood","volume":"1237","author":"Truver","year":"2024","journal-title":"J. Chromatogr. B"},{"issue":"Suppl1","key":"10.1016\/j.ab.2026.116158_bib19","article-title":"Quantitation and abundance of xylazine and xylazine metabolites in human urine and plasma by LC-MS\/MS","volume":"162","author":"Lin","year":"2024","journal-title":"Am. J. Clin. Pathol."},{"issue":"Suppl 1","key":"10.1016\/j.ab.2026.116158_bib20","article-title":"A quantitative LC-MS\/MS method for xylazine and metabolites in urine","volume":"162","author":"Orahoske","year":"2024","journal-title":"Am. J. Clin. Pathol."},{"issue":"20","key":"10.1016\/j.ab.2026.116158_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/17576180.2025.2572959","article-title":"Recent advances in the identification and quantification of xylazine and medetomidine in biological specimens","volume":"17","author":"Crews","year":"2025","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.ab.2026.116158_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/jalm\/jfae158","article-title":"The prevalence of xylazine in patient urine samples that were positive for fentanyl in Western New York","volume":"10","author":"Young","year":"2025","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.ab.2026.116158_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2021.07.010","article-title":"High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021","volume":"521","author":"Korn","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ab.2026.116158_bib24","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00414-025-03562-7","article-title":"The first report from Ankara on the presence of xylazine abuse in blood and urine samples using a validated LC-HRMS method","volume":"139","author":"\u00d6zt\u00fcrk","year":"2025","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.ab.2026.116158_bib25","series-title":"Bioanalytical Method Validation Guidance for Industry","year":"2018"},{"issue":"1","key":"10.1016\/j.ab.2026.116158_bib26","doi-asserted-by":"crossref","first-page":"lmaf079","DOI":"10.1093\/labmed\/lmaf079","article-title":"Comparison of the DRI II and LZI I fentanyl immunoassays for in vitro clinical diagnostic use","volume":"57","author":"Olaniyan","year":"2026","journal-title":"Lab. Med."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269726001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269726001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:46:28Z","timestamp":1780749988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269726001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0003269726001144"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2026.116158","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a quantitative LC\u2013MS\/MS method for assessment of xylazine in urine","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2026.116158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116158"}}